Incyte Corp at Morgan Stanley Global Healthcare Conference Transcript
Welcome, everyone, to this session of the Morgan Stanley Global Healthcare Conference. I'm Judah Frommer, one of the SMID biotech analysts here. We're very excited to have Incyte for this session, represented by Bill and Pablo. Maybe just a quick disclosure before we get into it.
For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. With any questions, contact your Morgan Stanley sales representative. All right. With that, welcome back. Bill, you joined the company a couple of months before the conference last year.So maybe you can provide a brief overview of how the company has evolved, both strategically and in the clinic over the last 12 months or so.
Thanks for having us. I think the most significant change over the past 12 months since I've joined, and to be fair, I
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
